DRKS00022325
Recruiting
未知
Cardiovascular Offensive by the Medizinische Praxisnetz Neumünster e.V.
nterstützt mit Mitteln des Strukturfonds zur Förderung anerkannter Praxisnetze gemäß §87b SGB V der Kassenärztlichen Vereinigung Schleswig-Holstein (KVSH)0 sites600 target enrollmentAugust 24, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- I10
- Sponsor
- nterstützt mit Mitteln des Strukturfonds zur Förderung anerkannter Praxisnetze gemäß §87b SGB V der Kassenärztlichen Vereinigung Schleswig-Holstein (KVSH)
- Enrollment
- 600
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients will be included if they have been treated with medication for arterial hypertension for at least six months and have given their written consent.
Exclusion Criteria
- •Patients will be excluded if they have not reached the age of 18 yet or cannot complete the questionnaire due to insufficient German language skills.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Comparison between 2 different hydration strategies (saline solution vs carbonati) for the prevention of contrast induced nephropaty in patients at risk for heart failure undergoing coronary angiography or interventioPatients undergoing coronary angiography or angioplastyMedDRA version: 14.1Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2011-003611-37-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA' DI NOVARA240
Active, not recruiting
Not Applicable
PRevEntion of cardiac and Vascular pEriprocedural complications in patients undergoiNg coronary angiography or angioplasTy: IntraCoronary Adenosine administration to prevent peRiprocedUral myonecrosiS in elective coronary angioplasty. A prospective double-blind randomized trial (PREVENT ICARUS) trial - PREVENT-ICARUSElective coronary angioplastyMedDRA version: 9.1Level: SOCClassification code 10047065EUCTR2009-013681-92-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA
Active, not recruiting
Not Applicable
Status of medical management of vascular risk factors before and after stroke in KoreaDiseases of the circulatory systemKCT0000671Seoul National University Hospital54,000
Completed
Not Applicable
Concurrent Treatment of Cardiovascular Disease in Peritoneal Dialysis (PD) patients. Multi-center Randomized Clinical Study with Aldosterone blockade (spironolactone) and Angiotensin Receptor Blocker (ARB) or Angiotensin-Converting-Enzyme Inhibitor (ACEI).End-Stage Renal Disease (ESRD) and Cardio-Vascular Disease (CVD)JPRN-UMIN000000492agoya University160
Recruiting
Not Applicable
Investigating cardiovascular adverse events related to cancer treatment: a study of extreme toxicity using induced pluripotent stem cellscardiovascular adverse events after cancer treatment1008220610027655NL-OMON44465niversitair Medisch Centrum Groningen48